106 related articles for article (PubMed ID: 8544798)
1. Clinical characteristics and factors affecting growth in long-term survivors of cancer.
Talvensaari KK; Knip M; Lanning P; Lanning M
Med Pediatr Oncol; 1996 Mar; 26(3):166-72. PubMed ID: 8544798
[TBL] [Abstract][Full Text] [Related]
2. Final height and weight of long-term survivors of childhood malignancies.
Müller HL; Klinkhammer-Schalke M; Kühl J
Exp Clin Endocrinol Diabetes; 1998; 106(2):135-9. PubMed ID: 9628245
[TBL] [Abstract][Full Text] [Related]
3. Reduction of adult height in childhood acute lymphoblastic leukemia survivors after prophylactic cranial irradiation.
Bongers ME; Francken AB; Rouwé C; Kamps WA; Postma A
Pediatr Blood Cancer; 2005 Aug; 45(2):139-43. PubMed ID: 15714445
[TBL] [Abstract][Full Text] [Related]
4. Hypothalamo-pituitary-adrenal axis integrity after cranial irradiation for childhood posterior fossa tumours.
Spoudeas HA; Charmandari E; Brook CG
Med Pediatr Oncol; 2003 Apr; 40(4):224-9. PubMed ID: 12555249
[TBL] [Abstract][Full Text] [Related]
5. No difference between prednisolone and dexamethasone treatment in bone mineral density and growth in long term survivors of childhood acute lymphoblastic leukemia.
van Beek RD; de Muinck Keizer-Schrama SM; Hakvoort-Cammel FG; van der Sluis IM; Krenning EP; Pieters R; van den Heuvel-Eibrink MM
Pediatr Blood Cancer; 2006 Jan; 46(1):88-93. PubMed ID: 15926166
[TBL] [Abstract][Full Text] [Related]
6. Longitudinal growth and risk factors for growth deficiency in children treated for acute lymphoblastic leukemia.
Vilela MI; Viana MB
Pediatr Blood Cancer; 2007 Jan; 48(1):86-92. PubMed ID: 16700045
[TBL] [Abstract][Full Text] [Related]
7. Height and weight in children treated for acute lymphoblastic leukemia: relationship to CNS treatment.
Dalton VK; Rue M; Silverman LB; Gelber RD; Asselin BL; Barr RD; Clavell LA; Hurwitz CA; Moghrabi A; Samson Y; Schorin M; Tarbell NJ; Sallan SE; Cohen LE
J Clin Oncol; 2003 Aug; 21(15):2953-60. PubMed ID: 12885815
[TBL] [Abstract][Full Text] [Related]
8. Obesity in survivors of childhood acute lymphoblastic leukemia and lymphoma.
Razzouk BI; Rose SR; Hongeng S; Wallace D; Smeltzer MP; Zacher M; Pui CH; Hudson MM
J Clin Oncol; 2007 Apr; 25(10):1183-9. PubMed ID: 17401007
[TBL] [Abstract][Full Text] [Related]
9. [Accretion of bone mass in patients treated for childhood acute lymphoblastic leukemia].
Muszyńska-Rosłan K; Konstantynowicz J; Krawczuk-Rybak M
Pol Merkur Lekarski; 2007 Oct; 23(136):271-5. PubMed ID: 18293849
[TBL] [Abstract][Full Text] [Related]
10. Progressive neurocognitive impairment in young adult survivors of childhood acute lymphoblastic leukemia.
Harila MJ; Winqvist S; Lanning M; Bloigu R; Harila-Saari AH
Pediatr Blood Cancer; 2009 Aug; 53(2):156-61. PubMed ID: 19405135
[TBL] [Abstract][Full Text] [Related]
11. Growth in children with poor-risk neuroblastoma after regimens with or without total body irradiation in preparation for autologous bone marrow transplantation.
Hovi L; Saarinen-Pihkala UM; Vettenranta K; Lipsanen M; Tapanainen P
Bone Marrow Transplant; 1999 Nov; 24(10):1131-6. PubMed ID: 10578163
[TBL] [Abstract][Full Text] [Related]
12. Final height in pediatric patients after hyperfractionated total body irradiation and stem cell transplantation.
Chemaitilly W; Boulad F; Heller G; Kernan NA; Small TN; O'Reilly RJ; Sklar CA
Bone Marrow Transplant; 2007 Jul; 40(1):29-35. PubMed ID: 17468769
[TBL] [Abstract][Full Text] [Related]
13. Growth hormone deficiency after chemotherapy for acute lymphoblastic leukemia in children who have not received cranial radiation.
Haddy TB; Mosher RB; Nunez SB; Reaman GH
Pediatr Blood Cancer; 2006 Feb; 46(2):258-61. PubMed ID: 16369923
[TBL] [Abstract][Full Text] [Related]
14. Bone mineral density in long-term survivors of childhood cancer.
Hesseling PB; Hough SF; Nel ED; van Riet FA; Beneke T; Wessels G
Int J Cancer Suppl; 1998; 11():44-7. PubMed ID: 9876477
[TBL] [Abstract][Full Text] [Related]
15. Hypertension and prehypertension in long-term survivors of childhood and adolescent cancer.
Haddy TB; Mosher RB; Reaman GH
Pediatr Blood Cancer; 2007 Jul; 49(1):79-83. PubMed ID: 16652349
[TBL] [Abstract][Full Text] [Related]
16. Is the treatment for childhood solid tumors associated with lower bone mass than that for leukemia and Hodgkin disease?
Muszynska-Roslan K; Konstantynowicz J; Panasiuk A; Krawczuk-Rybak M
Pediatr Hematol Oncol; 2009 Jan; 26(1):36-47. PubMed ID: 19206007
[TBL] [Abstract][Full Text] [Related]
17. Dose-effect relationships for adverse events after cranial radiation therapy in long-term childhood cancer survivors.
van Dijk IW; Cardous-Ubbink MC; van der Pal HJ; Heinen RC; van Leeuwen FE; Oldenburger F; van Os RM; Ronckers CM; Schouten-van Meeteren AY; Caron HN; Koning CC; Kremer LC
Int J Radiat Oncol Biol Phys; 2013 Mar; 85(3):768-75. PubMed ID: 22954771
[TBL] [Abstract][Full Text] [Related]
18. A comparative study of the long term psychosocial functioning of childhood acute lymphoblastic leukemia survivors treated by intrathecal methotrexate with or without cranial radiation.
Hill JM; Kornblith AB; Jones D; Freeman A; Holland JF; Glicksman AS; Boyett JM; Lenherr B; Brecher ML; Dubowy R; Kung F; Maurer H; Holland JC
Cancer; 1998 Jan; 82(1):208-18. PubMed ID: 9428499
[TBL] [Abstract][Full Text] [Related]
19. Bone mass and body composition after cessation of therapy for childhood cancer.
Nysom K; Mølgaard C; Holm K; Hertz H; Michaelsen KF
Int J Cancer Suppl; 1998; 11():40-3. PubMed ID: 9876476
[TBL] [Abstract][Full Text] [Related]
20. [A comparative study of the weight-height development of the long-term survivors of acute leukemia and solid tumors].
López Andreu JA; Albiach Mesado V; Ferrís i Tortajada J; Rodríguez Ineba A; Antonio Oriola P; Verdeguer Miralles A
An Esp Pediatr; 1999 Jun; 50(6):555-61. PubMed ID: 10410416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
